Back

Derivation and validation of a novel 3hour-pathway for the observe-zone of the ESC 0/1h-hs-cTnI algorithm

26 August 2023 (17:05 - 17:15)
Organised by: Logo
Congress Presentation Part of: Rule in/out of acute coronary syndromes in the emergency setting Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Pedro Lopez Ayala

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
A randomized clinical trial of sex and population-specific troponin cutoffs for ruling out acute MI - the danish study of sex and population-specific cutoffs of troponin (DANSPOT)
Doctor N. Strandkjaer (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Does the paradoxical effect of smoking on troponin impact the safety of the ESC 0/1h algorithm?
Doctor B. Toprak (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of stepwise 0/1/3h rule-out of myocardial infarction using high-sensitivity troponin T
Doctor J. Lehmacher (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
ESC 0/1h-algorithm using the updated, biotin-resistant high-sensitivity cardiac troponin T assay
Professor R. Twerenbold (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Diagnostic performance of the 0/2 hours ESC algorithm with high-sensitivity cardiac troponin T in an unselected community United States cohort
Doctor L. De Michieli (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Rule in/out of acute coronary syndromes in the emergency setting
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 17:05 CET
You may be interested in
thumbnail
Congress Session
Rule in/out of acute coronary syndromes in the emergency setting
thumbnail
Congress Presentation
Validation of the 0/3-h algorithm and the APACE criteria to triage patients in the observe-zone
thumbnail
Congress Presentation
Clinical validation of a point of care whole blood high sensitive cardiac troponin I assay: a prospective real time study on 3306 consecutive presentations with suspected acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources